B419 Pill - yellow capsule/oblong

Pill with imprint B419 is Yellow, Capsule/Oblong and has been identified as Meloxicam 15 mg. It is supplied by Chartwell RX, LLC.

Meloxicam is used in the treatment of Osteoarthritis; Juvenile Rheumatoid Arthritis; Rheumatoid Arthritis; Pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B419

Meloxicam

Imprint: B419
Strength: 15 mg
Color: Yellow (light yellow)
Shape: Capsule/Oblong (capsule shaped)
Availability: Prescription only
Drug Class: Nonsteroidal anti-inflammatory drugs
Pregnancy Category: C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule: Not a controlled drug
Labeler / Supplier: Chartwell RX, LLC
National Drug Code (NDC): 62135-0716